Modelling biphasic killing of fluoroquinolones: guiding optimal dosing regimen design

Abstract

Our model was found to be reasonable in characterizing biphasic killing of fluoroquinolones and predicting dosing regimens to suppress resistance development. Our work demonstrated improvements resulting from using the proposed mathematical modelling as a decision support tool for guiding the design of dosing regimens.